Senior insider sale
EVP, Research & Development at NOVAVAX INC — senior position signals high conviction
$296.1K
30K shares
What this filing means
DRAGHIA-AKLI RUXANDRA plans to sell 30K shares of NOVAVAX INC valued at approximately $296.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/7/2026ACC: 0001628280-26-032295
Officer· EVP, Research & Development
Since Mar 2026
30K
Shares to sell
$296.1K
Approx. market value
30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Plan Activity
n/a
5/7/2026
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/7/2026 | Stock Plan Activity n/a | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
30K
Market value
$296.1K
5/7/2026
Total
Units
30K
Value
$296.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/7/2026 | 30K | $296.1K | NASDAQ | Planned |
| Total | 30K | $296.1K | ||